Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

GE HealthCare Technologies (GEHC) Shares Issued (2023 - 2026)

GE HealthCare Technologies filings provide 4 years of Shares Issued readings, the most recent being $10.0 million for Q1 2026.

  • On a quarterly basis, Shares Issued fell 50.0% to $10.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.0 million, a 27.03% decrease, with the full-year FY2025 number at $37.0 million, up 12.12% from a year prior.
  • Shares Issued hit $10.0 million in Q1 2026 for GE HealthCare Technologies, down from $12.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $20.0 million in Q1 2025 to a low of $1.0 million in Q2 2025.
  • Median Shares Issued over the past 4 years was $7.5 million (2024), compared with a mean of $8.3 million.
  • The widest YoY moves for Shares Issued: up 500.0% in 2025, down 87.5% in 2025.
  • GE HealthCare Technologies' Shares Issued stood at $3.0 million in 2023, then tumbled by 33.33% to $2.0 million in 2024, then surged by 500.0% to $12.0 million in 2025, then decreased by 16.67% to $10.0 million in 2026.
  • The last three reported values for Shares Issued were $10.0 million (Q1 2026), $12.0 million (Q4 2025), and $4.0 million (Q3 2025) per Business Quant data.